Valiant Laboratories Appoints Internal and Cost Auditors for FY27
Valiant Laboratories Limited's Board of Directors has appointed Rajesh Chheda & Co. as Internal Auditors and Ketki D Visariya & Co. as Cost Auditors for FY 2026-27. Both appointments are effective from May 14, 2026.
The appointment of internal and cost auditors is a routine compliance requirement for companies and does not represent a significant strategic shift or financial event that would materially impact the company's operations or stock price.
The announcement pertains to the routine appointment of auditors, which is a standard corporate compliance activity and does not inherently carry a positive or negative financial implication.
Valiant Laboratories Limited announced the outcome of its Board Meeting held on May 14, 2026. The Board approved the appointment of Rajesh Chheda & Co. (Firm Registration No. 112887W) as the Internal Auditors for the Financial Year 2026-27. Additionally, Ketki D Visariya & Co., Cost Accountants (Firm Registration No. 000362), has been appointed as the Cost Auditors for the same fiscal year.
The appointments are effective from May 14, 2026, and are in accordance with the provisions of the Companies Act, 2013. Rajesh Chheda & Co. brings extensive experience in internal and statutory audits, tax audit services, and corporate consultancy. Ketki D Visariya & Co. has a proven track record of conducting cost audits across various industries, including pharmaceuticals, chemicals, and textiles.
The Board Meeting commenced at 3:30 P.M. and concluded at 5:30 P.M. This information is also available on the company's website, www.valiantlabs.in.
What to do with a filing like this
Valiant Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under auditor changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Laboratories Limited. Read the original for the full detail.